Jan 17,2019

Nemaura Medical Announces Improvement to SugarBEAT® Continuous Glucose Monitor

Nemaura Medical, Inc., a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced that it has substantially advanced the use-case for SugarBEAT® to improve management of glucose levels by spending more time in range.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 21,2019

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its fourth quarter and full year 2018 financial and operating results.

View Analyst & Ambassador Comments
Go to original news
Jan 23,2019

ABBOTT REPORTS 2018 RESULTS AND ISSUES STRONG FORECAST FOR 2019

In Diabetes Care, sales increased 28.3 percent on a reported basis and 32.4 percent on an organic basis in the fourth quarter, led by rapid market uptake of FreeStyle® Libre, Abbott's revolutionary sensor-based continuous glucose monitoring system, which removes the need for routine fingersticks3 for people with diabetes.

View Analyst & Ambassador Comments
Go to original news
Jan 24,2019

BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique

BD (Becton, Dickinson and Company) a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano(TM) pen needle, designed for more reliable subcutaneous injection depth.

REGULATORY FDA
View Analyst & Ambassador Comments
Go to original news
Jan 25,2019

Insulet to Announce Fourth Quarter and Full Year 2018 Financial Results on February 25, 2019

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year of 2018 on February 25, 2019 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Jan 28,2019

Insulet Appoints Corinne Nevinny to Board of Directors

Ms. Nevinny is the General Partner of LMNVC, a seed venture fund making early-round investments in start-up companies that have products or services that improve quality of life, including health and wellness oriented businesses. From 2003 to 2010, she served in a variety of roles at Edwards Lifesciences Corporation, including General Manager – Cardiac Surgery Systems, President of Global Operations, and Chief Financial Officer and Treasurer. In these roles, Ms. Nevinny was at various times responsible for global sales, manufacturing, quality and supply chain operations, as well as oversight of core operating units including finance, IT, internal audit and risk management.

View Analyst & Ambassador Comments
Go to original news
Jan 29,2019

Former Walgreens SVP Chief Healthcare Commercial Market Development Officer Brad Fluegel Joins Cecelia Health Board of Advisors

Brad Fluegel’s extensive experience in long-term strategic planning, marketing, business development, innovation and new business ventures will support Cecelia Health’s mission to transform the lives and health outcomes of people living with diabetes and related chronic diseases by scaling personalized expert clinical coaching through the use of technology.

View Analyst & Ambassador Comments
Go to original news
Jan 31,2019

One Drop Launches Personal Diabetes Assistant and Integrates with Health Records on iPhone

One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Personal Diabetes Assistant, a powerful new approach to supporting people with diabetes in their day-to-day self-management. The company also announced integration with Health Records on iPhone, empowering all One Drop iOS users to seamlessly share their electronic health records with their personal coaches through the One Drop platform.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Feb 18,2019

Novo Nordisk's soon-to-be-released insulin pens will connect to Glooko's diasend platform

This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. As part of today’s announcement Glooko also revealed a new compatibility feature for the Dexcom G6 continuous glucose monitor.

COLLABORATION PARTNERSHIP

#connected device

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Feb 19,2019

FDA grants De Novo clearance to interoperable insulin pump

The Tandem Diabetes Care t:Slim X2 insulin pump was reviewed through the De Novo premarket review pathway, making it the first of a new medical device category called Alternate Controller Enabled (ACE) infusion pumps. Intended for use by both adults and children with diabetes, the digital device automatically receives insulin dosing commands from a diabetes management device once connected, or can independently infuse insulin when it is on its own.

REGULATORY FDA

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES